6505--Metformin 24HR SA Tablets PPV
ID: 36E79725R0051Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/29a334703414460eb4970408ec9b0ade/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the supply of Metformin Hydrochloride (HCL) 24HR Sustained Action (SA) Tablets through solicitation 36E79725R0051. This procurement aims to secure a consistent supply of essential pharmaceutical products for the VA and other federal healthcare facilities, ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA standards. The deadline for submitting proposals has been extended to August 25, 2025, at 2:30 PM Central Time, and offerors must include a completed and signed copy of the amendment with their proposals. For further inquiries, interested parties can contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.

    Point(s) of Contact
    Youlanda DuggarContract Specialist
    youlanda.duggar@va.gov
    Files
    Title
    Posted
    36E79725R0051 0001.docx
    The Department of Veterans Affairs, National Acquisition Center, has issued an amendment (0001) to solicitation 36E79725R0051. This amendment, effective July 22, 2025, extends the deadline for offers for Metformin Hydrochloride (HCL) 24HR Sustained Action (SA) Tablets. The new due date for proposal submissions is August 11, 2025, at 2:30 PM Central Time. All other terms and conditions of the original solicitation remain unchanged. Offerors must acknowledge receipt of this amendment by including a completed and signed copy with their proposal.
    36E79725R0051 0002.docx
    The Department of Veterans Affairs has issued Amendment 0002 to Solicitation 36E79725R0051, extending the deadline for offers for Metformin Hydrochloride (HCL) 24HR Sustained Action (SA) Tablets. The new due date and time for proposal submissions is August 25, 2025, at 2:30 PM Central Time. All other terms and conditions of the original solicitation remain unchanged. Offerors are required to acknowledge receipt of this amendment by including a completed and signed copy with their proposal to ensure their offer is considered.
    36E79725R0051_1.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0051 concerning the procurement of Metformin HCL Tablets, 24HR SA in various bottle sizes for the VA, Department of Defense (DoD), and other federal entities. The contract, which can extend up to five years, aims to ensure a consistent supply of these medications. Offerors must provide unique NDC numbers and specific packaging requirements, including safety caps and suitable bottle dimensions. The solicitation is set to be released electronically on or about July 14, 2025, with a response deadline of July 28, 2025. Estimated annual usage for the various tablet formulations ranges significantly, with the largest demand for 500 and 1,000 tablet bottles. The notice emphasizes the requirement for contractors who can maintain uninterrupted supply, facilitates accessibility for interested parties to track updates via SAM.gov, and provides contact information for inquiries. Overall, the presolicitation demonstrates the VA's commitment to fulfilling its pharmaceutical needs effectively for veterans and affiliated organizations.
    36E79725R0051.docx
    The document outlines a Request for Proposal (RFP) by the Department of Veterans Affairs (VA) for pharmaceutical products through their Pharmaceutical Prime Vendor Programs. It seeks a contractor to supply specific medications, particularly various forms of Metformin Hydrochloride tablets, for a term beginning on the contract award date and lasting through a base year with four option years. Key requirements include submission of pricing proposals for multiple line items, compliance with the Drug Supply Chain Security Act (DSCSA), and ensuring manufacturing facilities meet FDA standards. Contractors must submit a unique National Drug Code (NDC) for each product, maintain agreements with Prime Vendors, and meet rigorous packaging and labeling standards. The contract stipulates a 0.5% Cost Recovery Fee embedded in pricing that vendors must collect and report quarterly. Backorder procedures are also detailed, specifying the contractor's responsibilities to alleviate supply disruptions. Overall, the RFP focuses on securing a consistent supply of pharmaceuticals for VA and other federal healthcare facilities while ensuring compliance with rigorous regulatory and safety standards.
    36E79725R0051 0001.docx
    This document is an amendment to solicitation number 36E79725R0051, issued by the Department of Veterans Affairs, specifically the OPAL / National Acquisition Center. Its primary purpose is to extend the submission deadline for offers regarding Metformin Hydrochloride (HCL) 24HR Sustained Action (SA) Tablets from July 28, 2025, to August 11, 2025, at 2:30 PM Central Time. All other terms and conditions of the original solicitation remain unchanged. Offerors are required to submit a completed and signed copy of this amendment alongside their proposals. The amendment emphasizes the importance of timely submission and acknowledgment of receipt to prevent rejection of offers. The amendment highlights procedural compliance within the context of government procurement processes, ensuring clarity for all bidders involved. The document is structured formally, identifying numerous administrative details, including project numbers, contractor information, and the signatures of the contracting officer, thereby ensuring all communication is appropriately documented and authorized.
    Lifecycle
    Title
    Type
    6505--Metformin 24HR SA Tablets PPV
    Currently viewing
    Solicitation
    6505--Metformin 24HR SA Tablets PPV
    Presolicitation
    Similar Opportunities
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    Metformin HCL ER
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is procuring Metformin HCL ER. Metformin HCL ER is a drug used to treat type 2 diabetes. This procurement is being conducted by DLA TROOP SUPPORT. For more information, contact Christopher Newman at christopher.newman@dla.mil or 2157372905.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.